Overall survival and morbidity are not associated with advanced age for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience
oleh: Cheng Ernest, Shamavonian Raphael, Mui Jasmine, Hayler Raymond, Karpes Josh, Wijayawardana Ruwanthi, Barat Shoma, Ahmadi Nima, Morris David L.
| Format: | Article |
|---|---|
| Diterbitkan: | De Gruyter 2023-04-01 |
Deskripsi
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) has enabled better prognosis for patients with peritoneal surface malignancies. However, in older age groups, short -and long-term outcomes are still perceived as poor. We evaluated patients aged 70 and over and determine if age is a predictor of morbidity, mortality and overall survival (OS).